These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7202476)

  • 1. Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man.
    Jogestrand T; Sundqvist K
    Eur J Clin Pharmacol; 1981 Jan; 19(2):89-95. PubMed ID: 7202476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatment.
    Jogestrand T; Ericsson F; Sundqvist K
    Eur J Clin Pharmacol; 1981 Jan; 19(2):97-105. PubMed ID: 7202477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral salbutamol decreases serum digoxin concentration.
    Edner M; Jogestrand T
    Eur J Clin Pharmacol; 1990; 38(2):195-7. PubMed ID: 2338119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of salbutamol on digoxin concentration in serum and skeletal muscle.
    Edner M; Jogestrand T
    Eur J Clin Pharmacol; 1989; 36(3):235-8. PubMed ID: 2744063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of digoxin upon intracellular potassium in man.
    Ericsson F; Carlmark B; Jogestrand T; Sundqvist K
    Scand J Clin Lab Invest; 1981 Sep; 41(5):457-63. PubMed ID: 7313528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical exercise and digoxin binding to skeletal muscle: relation to exercise intensity.
    Joreteg T; Jogestrand T
    Eur J Clin Pharmacol; 1983; 25(5):585-8. PubMed ID: 6662158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.
    Jogestrand T
    Eur J Clin Pharmacol; 1980 Apr; 17(4):243-50. PubMed ID: 7398729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle binding and renal excretion of digoxin in man.
    Schenck-Gustafsson K; Jogestrand T; Dahlqvist R
    Eur J Clin Pharmacol; 1987; 31(5):601-3. PubMed ID: 3830246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle digoxin binding in patients with renal failure.
    Jogestrand T; Ericsson F
    Br J Clin Pharmacol; 1983 Jul; 16(1):109-11. PubMed ID: 6882618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of salbutamol on digoxin pharmacokinetics.
    Edner M; Jogestrand T; Dahlqvist R
    Eur J Clin Pharmacol; 1992; 42(2):197-201. PubMed ID: 1618253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockade and binding of digoxin to skeletal muscle.
    Joreteg T; Jogestrand T
    Clin Physiol; 1986 Apr; 6(2):183-90. PubMed ID: 3006980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial and skeletal muscle concentrations of digoxin in patients on long-term therapy.
    Coltart J; Howard M; Chamberlain D
    Br Med J; 1972 May; 2(5809):318-9. PubMed ID: 4623290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical exercise and binding of digoxin to skeletal muscle--effect of muscle activation frequency.
    Joreteg T; Jogestrand T
    Eur J Clin Pharmacol; 1984; 27(5):567-70. PubMed ID: 6519161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and tissue digoxin concentrations in patients undergoing cardiopulmonary bypass.
    Carruthers SG; Cleland J; Kelly JG; Lyons SM; McDevitt DG
    Br Heart J; 1975 Mar; 37(3):313-20. PubMed ID: 1138734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinidine-induced changes in serum and skeletal muscle digoxin concentration; evidence of saturable binding of digoxin to skeletal muscle.
    Jogestrand T; Schenck-Gustafsson K; Nordlander R; Dahlqvist R
    Eur J Clin Pharmacol; 1984; 27(5):571-5. PubMed ID: 6519162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of digoxin: relationship between response intensity and predicted compartmental drug levels in man.
    Kramer WG; Kolibash AJ; Lewis RP; Bathala MS; Visconti JA; Reuning RH
    J Pharmacokinet Biopharm; 1979 Feb; 7(1):47-61. PubMed ID: 458556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue digoxin concentrations and digoxin effect during the quinidine-digoxin interaction.
    Warner NJ; Barnard JT; Bigger JT
    J Am Coll Cardiol; 1985 Mar; 5(3):680-6. PubMed ID: 3973266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of digoxin on the heart in normal subjects: influence of isometric exercise and autonomic blockade: a noninvasive study.
    Partanen J; Heikkilä J; Pellinen T; Nieminen MS
    Br J Clin Pharmacol; 1988 Mar; 25(3):331-40. PubMed ID: 3358896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac effects of treatment with quinidine and digoxin, alone and in combination.
    Schenck-Gustafsson K; Jogestrand T; Brodin LA; Nordlander R; Dahlqvist R
    Am J Cardiol; 1983 Mar; 51(5):777-82. PubMed ID: 6829437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac effects and glycoside concentrations in serum and urine after oral administration of beta-methy-digoxin to healthy individuals (author's transl)].
    Haasis R; Larbig D; Klenk KO
    Klin Wochenschr; 1975 Jun; 53(11):529-33. PubMed ID: 1152344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.